Headlines Biopharma-Culture 
pharmaphorum
DECEMBER 28, 2022
In pharma, multi-billion-dollar deals dominate M&A headlines, but most deals are far shorter of this range and generally lie between $10-$500 million. In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. Post-acquisition compliance.
Pharmaceutical Technology
FEBRUARY 28, 2023
Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. This can result in reductions in costs for our customers.”
Drug Discovery World
APRIL 27, 2023
In 2021, biopharma employment grew in the region by 13.2% The Boston Globe headline 3 , ‘Life sciences is poised to be Boston’s dominant industry. FUJIFILM Irvine Scientific recently announced plans to build a cell culture media manufacturing facility in RTP. Has the area become the Silicon Valley of biotech?’
Expert insights. Personalized for you.
119 
Let's personalize your content